Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Psychopharmacology Bulletin|October 26, 2002
A pharmacokinetic drug-drug interaction study of venlafaxine and indinavirG M Levin, L A Nelson, C L DeVane, et al.Pharmacopsychiatry|May 1, 1984
The metyrapone test in manic patients and healthy subjectsG I Perini, G A Fava, M A Morphy, et al.Journal of Affective Disorders|December 1, 1984
The metyrapone test in affective disorders and schizophrenia II. Changes upon treatmentG I Perini, G A Fava, M A Morphy, et al.Neuropsychobiology|January 1, 1985
The metyrapone test in schizophrenic patients and healthy subjectsM A Morphy, G A Fava, S W Carson, et al.Clinical Pharmacology and Therapeutics|April 1, 1994
Lithium pharmacokinetics in the obeseR A Reiss, C E Haas, S D Karki, et al.Life Sciences|March 4, 2000
Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteersJ S Markowitz, C L DeVane, D W Boulton, et al.Biological Psychiatry|February 10, 1999
The effects of serotonin3 receptor blockade on the psychobiological response to intravenous clomipramine in healthy human subjectsM E Leatherman, J M Bebchuk, R D Ekstrom, et al.Anxiety|January 1, 1994
Neuroendocrine responsivity to monoaminergic system probes in generalized social phobiaM E Tancer, R B Mailman, M B Stein, et al.Journal of Clinical Psychopharmacology|June 1, 2000
Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizersC L DeVane, J S Markowitz, S W Carson, et al.Biological Psychiatry|December 15, 1993
Altered prolactin response to clomipramine rechallenge in healthy subjectsJ H Gilmore, R G Ruegg, R D Ekstrom, et al.Pageof 4